Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
Condition(s):Motor Neuron Disease; Amyotrophic Lateral SclerosisLast Updated:March 14, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Motor Neuron Disease; Amyotrophic Lateral SclerosisLast Updated:March 14, 2019Completed
Condition(s):Amyotrophic Lateral SclerosisLast Updated:June 24, 2020Withdrawn
Condition(s):Visual PerformanceLast Updated:August 7, 2018Completed
Condition(s):PharmacokineticsLast Updated:September 10, 2020Completed
Condition(s):Cognitive DysfunctionLast Updated:January 16, 2019Unknown status
Condition(s):ArthritisLast Updated:December 8, 2023Active, not recruiting
Condition(s):Gram-Negative Bacterial InfectionsLast Updated:October 2, 2019Completed
Condition(s):MalariaLast Updated:February 8, 2017Completed
Condition(s):Proximal or Diaphyseal Humerus Fracture; Diaphyseal or Distal Femur Fracture; Diaphyseal, Distal or Proximal Tibia FractureLast Updated:January 21, 2016Withdrawn
Condition(s):MalariaLast Updated:June 5, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.